Status:
COMPLETED
rhuFVIIa in Post-partum Hemorrhage
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Collaborating Sponsors:
University Hospital, Lille
Assistance Publique - Hôpitaux de Paris
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The aim of this clinical research project is to evaluate the use of the recombinant human activated factor VII (rhFVIIa), given as a salvage therapy, in women with a dramatic postpartum hemorrhage sti...
Detailed Description
Depending on the country and the publications, postpartum hemorrhage is either the first or the second cause of maternal death in the world, including developed countries. According to the WHO, it is ...
Eligibility Criteria
Inclusion
- Severe postpartum hemorrhage, i.e non responsive to sulprostone infusion
Exclusion
- \< 18 years
- personal antecedent of arterial or venous thrombosis
- written informed consent not approved/signed by the patient or her husband
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00370877
Start Date
April 1 2007
End Date
November 1 2010
Last Update
March 27 2015
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Lille
Lille, Lille, France
2
University Hospital of Montpellier
Montpellier, Montpellier, France
3
University Hospital, Nice
Nice, Nice, France
4
Hôpital Antoine Béclère -APHP
Clamart, France